The growing paradigm of preventing disease: Vaccines to prevent herpes zoster and pertussis in adults

Annals of Internal Medicine

Volumn 143, Issue 7, 2005, Pages 539-541

  Poland, Gregory A ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHICKENPOX VACCINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; DIPHTHERIA TETANUS VACCINE; PERTUSSIS VACCINE; VARICELLA ZOSTER VACCINE;

ADULT; BACTERIAL INFECTION; DRUG EFFICACY; DRUG SAFETY; HERPES ZOSTER; HUMAN; IMMUNIZATION; IMMUNOGENICITY; PERTUSSIS; PRIORITY JOURNAL; REVIEW; VACCINATION; VIRUS INFECTION;

EID: 25444455319     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-143-7-200510040-00013     Document Type: Review

References (28)

1. Oxman MN, Levin MJ, Johnson GR, Schmader KE, Straus SE, Gelb LD, et al. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med. 2005;352:2271-84. [PMID: 15930418]
2. Pichichero ME, Rennels MB, Edwards KM, Blatter MM, Marshall GS, Bologa M, et al. Combined tetanus, diphtheria, and 5-component pertussis vaccine for use in adolescents and adults. JAMA. 2005;293:3003-11. [PMID: 15933223]
3. Ragozzino MW, Melton LJ 3rd, Kurland LT, Chu CP, Peny HO. Population-based study of herpes zoster and its sequelae. Medicine (Baltimore). 1982;61:310-6. [PMID: 6981045]
4. Miller AE. Selective decline in cellular immune response to varicella-zoster in the elderly. Neurology. 1980;30:582-7. [PMID: 6247671]
5. Levin MJ, Hayward AR. The varicella vaccine. Prevention of herpes zoster. Infect Dis Clin North Am. 1996;10:657-75. [PMID: 8856358]
6. Berger R, Luescher D, Just M. Restoration of varicella-zoster virus cell-mediated immune response after varicella booster vaccination. Postgrad Med J. 1985(Suppl);143-5. [PMID: 3014472]
7. Levin MJ, Murray M, Zerbe GO, White CJ, Hayward AR. Immune responses of elderly persons 4 years after receiving a live attenuated varicella vaccine. J Infect Dis. 1994;170:522-6. [PMID: 8077709]
8. Levin MJ, Murray M, Rotbart HA, Zerbe GO, White CJ, Hayward AR. Immune response of elderly individuals to a live attenuated varicella vaccine. J Infect Dis. 1992;166:253-9. [PMID: 1321859]
9. De Serres G, Shadmani R, Duval B, Boulianne N, Déry P, Douville Fradet M, et al. Morbidity of pertussis in adolescents and adults. J Infect Dis. 2000;182:174-9. [PMID: 10882595]
10. Yih WK, Lett SM, des Vignes FN, Garrison KM, Sipe PL, Marchant CD. The increasing incidence of pertussis in Massachusetts adolescents and adults, 1989-1998. J Infect Dis. 2000;182:1409-16. [PMID: 11023464]
11. Halperin SA, Marrie TJ. Pertussis encephalopathy in an adult: case report and review. Rev Infect Dis. 1991;13:1043-7. [PMID: 1775835]
12. Edwards KM. Pertussis epidemiology and transmission. Advanced Studies in Medicine. 2005;S440-S443.
13. Nennig ME, Shinefield HR, Edwards KM, Black SB, Fireman BH. Prevalence and incidence of adult pertussis in an urban population. JAMA. 1996;275:1672-4. [PMID: 8637142]
14. Wright SW, Edwards KM, Decker MD, Zeldin MH. Pertussis infection in adults with persistent cough. JAMA. 1995;273:1044-6. [PMID: 7897789]
15. Rosenthal S, Strebel P, Cassiday P, Sanden G, Brusuelas K, Wharton M. Pertussis infection among adults during the 1993 outbreak in Chicago. J Infect Dis. 1995;171:1650-2. [PMID: 7769311]
16. Senzilet LD, Halperin SA, Spika JS, Alagaratnam M, Morris A, Smith B, et al. Pertussis is a frequent cause of prolonged cough illness in adults and adolescents. Clin Infect Dis. 2001;32:1691-7. [PMID: 11360208]
17. Keitel WA, Edwards KM. Pertussis in adolescents and adults: time to re-immunize; Semin Respir Infect. 1995;10:51-7. [PMID: 7761714]
18. Linnemann CC Jr, Ramundo N, Perlstein PH, Minton SD, Englender GS. Use of pertussis vaccine in an epidemic involving hospital staff. Lancet. 1975;2:540-3. [PMID: 51354]
19. Keitel WA. Cellular and acellular pertussis vaccines in adults. Clin Infect Dis. 1999;28 Suppl 2:5118-23. [PMID: 10447029]
20. Englund JA, Glezen WP, Barreto L. Controlled study of a new five-component acellular pertussis vaccine in adults and young children. J Infect Dis. 1992;166:1436-41. [PMID: 1431261]
21. Rothstein EP, Anderson EL, Decker MD, Poland GA, Reisinger KS, Blatter MM, et al. An acellular pertussis vaccine in healthy adults: safety and immunogenicity. Pennridge Pediatric Associates. Vaccine. 1999;17:2999-3006. [PMID: 10462235]
22. Tran Minh NN, He Q, Edelman K, Putto-Laurila A, Arvilommi H, Viljanen MK, et al. Immune responses to pertussis antigens eight years after booster immunization with acellular vaccines in adults. Vaccine. 2000;18:1971-4. [PMID: 10706957]
23. Halperin SA, Smith B, Russell M, Hasselback P, Guasparini R, Skowronski D, et al. An adult formulation of a five-component acellular pertussis vaccine combined with diphtheria and tetanus toxoids is safe and immunogenic in adolescents and adults. Vaccine. 2000;18:1312-9. [PMID: 10618527]
24. Poland GA. Acellular pertussis vaccines: new vaccines for an old disease. Lancet. 1996;347:209-10. [PMID: 8551875]
25. Poland GA. Still more questions on pertussis vaccines. Lancet. 1997;350:1564-5. [PMID: 9393330]
26. Gustafsson L, Hallander HO, Olin P, Reizenstein E, Storsaeter J. A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine. N Engl J Med. 1996;334:349-55. [PMID: 8538705]
27. Robbins JB. Pertussis in adults: introduction. Clin Infect Dis. 1999;28 Suppl 2:S91-3. [PMID: 10447024]
28. Adult immunization initiative. Available at www.acponline.org/aii/index. html. Accessed 6 July 2005.